• Users Online: 1277
  • Home
  • Print this page
  • Email this page
CLINICAL PRACTICE
Year : 2014  |  Volume : 9  |  Issue : 6  |  Page : 653-660

APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease


1 Key Laboratory of Geriatrics, Beijing Hospital & Beijing Institute of Geriatrics, Ministry of Health, Beijing; Department of Neurology, Jiangbin Hospital, Nanning, Guangxi Zhuang Autonomous Region, China
2 Key Laboratory of Geriatrics, Beijing Hospital & Beijing Institute of Geriatrics, Ministry of Health, Beijing, China
3 Department of Neurology, Jiangbin Hospital, Nanning, Guangxi Zhuang Autonomous Region, China
4 Human Health Therapeutics, National Research Council of Canada, Ottawa, Canada

Correspondence Address:
Caiyou Hu
Department of Neurology, Jiangbin Hospital, Nanning 530021, Gua ngxi Zhuang Autonomous Region, China

Wandong Zhang
Human Health Therapeutics, National Research Council of Canada, Ottawa, Canada

Ze Yang
Key Laboratory of Geriatrics, Beijing Hospital ? Beijing Institute of Geriatrics, Ministry of Health, Beijing 100730, China

Login to access the Email id

Source of Support: Funding: This study was supported by the National Natural Science Foundation of China, No. 81370445, 81061120527, 81241082; Major Funding from Beijing Hospital, No. BJ-2010-30; Key Project of Clinical Disciplines at the Subordinate Hospital, Ministry of Health, No. 10120101; National Department Public Benefit Research Foundation by the Ministry of Health, No. 201302008; 12th 5-year National Program from Ministry of Scientific Technology, No. 2012BAI10B01; Science and Technology Development Foundation of Guangxi Zhuang Autonomous Region, No. 1355005-6- 2; and Canadian Institute of Health Research (CIHR), No. 109606., Conflict of Interest: None


DOI: 10.4103/1673-5374.130117

Rights and Permissions

Current evidence shows that apolipoprotein E (APOE), apolipoprotein CI (APOC1) and low density lipoprotein receptor-related protein (LRP) variations are related to late-onset Alzheimer's disease. However, it remains unclear if genetic polymorphisms in these genes are associated with cognitive decline in late-onset Alzheimer's disease patients. We performed a 30-month longitudinal cohort study to investigate the relationship between Alzheimer's disease and APOE, APOC1, and LRP. In this study, 78 Chinese Han patients with late-onset Alzheimer's disease were recruited form Guangxi Zhuang Autonomous Region in China. APOE, APOC1, and LRP genotyping was performed using polymerase chain reaction-restriction fragment length polymorphisms. The Mini-Mental State Examination and Clinical Dementia Rating Scale were used to assess patients' cognitive function. After a 30-month follow-up period, we found a significant reduction in Mini-Mental State Examination total score, a higher proportion of patients fulfilling cognitive impairment progression criteria, and a higher proportion of APOC1 H2 carriers in APOE ε4 carriers compared with non-carriers. In addition, the APOE ε4 allele frequency was significantly higher in the cognitive impairment progression group compared with the non-cognitive impairment progression group. In conclusion, APOE ε4 plays an important role in augmenting cognitive decline, and APOC1 H2 may act synergistically with APOE ε4 in increasing the risk of cognitive decline in Chinese patients with late-onset Alzheimer's disease.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed3027    
    Printed48    
    Emailed0    
    PDF Downloaded492    
    Comments [Add]    
    Cited by others 8    

Recommend this journal